| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4791008
Max Phase: Preclinical
Molecular Formula: C19H14N4O3S
Molecular Weight: 378.41
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Cc1ccccc1NC(=O)c1ccc2[nH]c(-c3ccc([N+](=O)[O-])s3)nc2c1
Standard InChI: InChI=1S/C19H14N4O3S/c1-11-4-2-3-5-13(11)22-19(24)12-6-7-14-15(10-12)21-18(20-14)16-8-9-17(27-16)23(25)26/h2-10H,1H3,(H,20,21)(H,22,24)
Standard InChI Key: SPKHZUGOOUIEQV-UHFFFAOYSA-N
Associated Targets(non-human)
Hemozoin 239 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 378.41 | Molecular Weight (Monoisotopic): 378.0787 | AlogP: 4.76 | #Rotatable Bonds: 4 |
| Polar Surface Area: 100.92 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.78 | CX Basic pKa: 3.29 | CX LogP: 4.77 | CX LogD: 4.77 |
| Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.39 | Np Likeness Score: -2.06 |
References
| 1. Sharma, Mousmee, Prasher, Parteek. (2020) An epigrammatic status of the azole-based antimalarial drugs, 11 (2): [PMID:33479627] [10.1039/c9md00479c] |
Source
Source(1):